GPCR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as PreRevenue Biotech Advances Pipeline SCSC Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Rises 328 BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market GPCR Q1 2026 Earnings Narrower Loss Highlights ClinicalStage Progress TOWN Q1 2026 Earnings EPS Misses Estimates But Stock Edges Higher QUAD Q1 2026 Earnings EPS Beat Underpins Cost Discipline Stock Edges Higher